Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Waller

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Postgraduate Medical Journal|July 1, 1997
Adverse drug reaction of the month--a new seriesM D Rawlins, A M Breckenridge, S M Wood, et al.
Journal of Human Hypertension|June 1, 1988
Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease?P C Waller, C G Isles, A F Lever, et al.
BMJ (Clinical Research Ed.)|June 6, 1992
Review of company postmarketing surveillance studiesP C Waller, S M Wood, M J Langman, et al.
Current Medical Research and Opinion|January 1, 1990
A placebo-controlled, double-blind study of eicosapentaenoic acid-rich fish oil in patients with stable angina pectorisS A Solomon, I Cartwright, G Pockley, et al.
British Heart Journal|December 1, 1995
Appetite suppressants and primary pulmonary hypertension in the United KingdomS H Thomas, A Y Butt, P A Corris, et al.
Thrombosis Research|April 15, 1987
Lack of effect of a 24-hour infusion of iloprost in intermittent claudicationC R Hay, P C Waller, C Carter, et al.
The American Journal of Medicine|April 1, 1989
Comparison of enalapril and atenolol in mild to moderate hypertensionA L Herrick, P C Waller, K E Berkin, et al.
Journal of Human Hypertension|February 1, 1993
Effects of atenolol withdrawal in patients on triple antihypertensive therapyE G Bevan, S D Pringle, P C Waller, et al.
Journal of Human Hypertension|February 1, 1993
Comparison of captopril, hydralazine and nifedipine as third drug in hypertensive patientsE G Bevan, S D Pringle, P C Waller, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Postgraduate Medical Journal|July 1, 1997
Adverse drug reaction of the month--a new seriesM D Rawlins, A M Breckenridge, S M Wood, et al.
Journal of Human Hypertension|June 1, 1988
Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease?P C Waller, C G Isles, A F Lever, et al.
BMJ (Clinical Research Ed.)|June 6, 1992
Review of company postmarketing surveillance studiesP C Waller, S M Wood, M J Langman, et al.
Current Medical Research and Opinion|January 1, 1990
A placebo-controlled, double-blind study of eicosapentaenoic acid-rich fish oil in patients with stable angina pectorisS A Solomon, I Cartwright, G Pockley, et al.
British Heart Journal|December 1, 1995
Appetite suppressants and primary pulmonary hypertension in the United KingdomS H Thomas, A Y Butt, P A Corris, et al.
Thrombosis Research|April 15, 1987
Lack of effect of a 24-hour infusion of iloprost in intermittent claudicationC R Hay, P C Waller, C Carter, et al.
The American Journal of Medicine|April 1, 1989
Comparison of enalapril and atenolol in mild to moderate hypertensionA L Herrick, P C Waller, K E Berkin, et al.
Journal of Human Hypertension|February 1, 1993
Effects of atenolol withdrawal in patients on triple antihypertensive therapyE G Bevan, S D Pringle, P C Waller, et al.
Journal of Human Hypertension|February 1, 1993
Comparison of captopril, hydralazine and nifedipine as third drug in hypertensive patientsE G Bevan, S D Pringle, P C Waller, et al.
Pageof 5